Publications in VIVO

Co-author Network

Co-investigator Network

Mary-Claire Roghmann, MD, MS

Dr. Dr.

Positions

Staff Physician and Health Research, VA Maryland HCS 1997 -
Professor, University of Maryland School of Medicine 1997 -

Location

Baltimore, MD

Dr. Roghmann is an infectious disease physician and clinical investigator. She is a Professor in the Departments of Epidemiology and Public Health and Medicine. She is Associate Dean for Physician Scientist Training and directs the Medical Scientist Training Program (MSTP). In addition, she works closely with the Research Career Development Program in promoting team and collaborative science. She also leads the Research Education Core of our NIH funded Pepper Center. She is also a Research Health Scientist, GRECC Investigator and Staff Physician for the VA Maryland Health Care System.

Clinical Disciplines

Publications
Research
Other
View All

Selected Publications

article
1. Association Between Foot Surgery Type and Subsequent Healing in Veterans With Moderate-to-Severe Diabetic Foot Infections.. Open forum infectious diseases. 9:-. 2021
2. Short-Stay Admissions Associated With Large COVID-19 Outbreaks in Maryland Nursing Homes.. Gerontology & geriatric medicine. -. 2021
3. Effect of mupirocin for Staphylococcus aureus decolonization on the microbiome of the nose and throat in community and nursing home dwelling adults.. PloS one. 16:-. 2021
4. Association between level of care and colonization with resistant gram-negative bacteria among nursing-home residents.. Infection control and hospital epidemiology. 42:760-762. 2021
5. Nursing home visitation restrictions during COVID-19-Balancing compassion and safety.. American journal of infection control. 49:-. 2021
6. Reply to Evans et al.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 71:2770-2771. 2020
7. Pseudomonas aeruginosa. Open forum infectious diseases. 7:-. 2020
8. The Effectiveness of Contact Precautions on Methicillin-Resistant Staphylococcus aureus in Long-term Care Across the United States.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 71:1676-1683. 2020
9. Staphylococcus aureus. Infection control and hospital epidemiology. 42:448-454. 2020
10. Association of Pressure injury with body care activities in nursing homes.. Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society. 29:53-59. 2020
11. Staphylococcus aureus. Infection control and hospital epidemiology. 41:1396-1401. 2020
12. Lessons learned - Outbreaks of COVID-19 in nursing homes.. American journal of infection control. 48:1279-1280. 2020
13. Frequency of nursing home resident contact with staff, other residents, and the environment outside resident rooms.. Infection control and hospital epidemiology. 40:815-816. 2019
14. Development and Validation of a Clinical Prediction Rule to Predict Transmission of Methicillin-Resistant Staphylococcus aureus in Nursing Homes.. American journal of epidemiology. 188:214-221. 2019
15. Transmission of resistant Gram-negative bacteria to healthcare personnel gowns and gloves during care of residents in community-based nursing facilities.. Infection control and hospital epidemiology. 39:1425-1430. 2018
16. The Impact of Isolation on Healthcare Worker Contact and Compliance With Infection Control Practices in Nursing Homes.. Infection control and hospital epidemiology. 39:683-687. 2018
17. Improving regulation of microbiota transplants.. Science (New York, N.Y.). 358:1390-1391. 2017
18. Transmission of Resistant Gram-Negative Bacteria to Health Care Worker Gowns and Gloves during Care of Nursing Home Residents in Veterans Affairs Community Living Centers.. Antimicrobial agents and chemotherapy. 61. 2017
19. Comparison of the Microbiota of Older Adults Living in Nursing Homes and the Community.. mSphere. 2. 2017
20. Clostridium difficile Colonization of Nursing Home Residents.. Infection control and hospital epidemiology. 38:1267-1268. 2017
21. Comparative Effectiveness of Cefazolin Versus Nafcillin or Oxacillin for Treatment of Methicillin-Susceptible Staphylococcus aureus Infections Complicated by Bacteremia: A Nationwide Cohort Study.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 65:100-106. 2017
22. Factors Leading to Transmission Risk of Acinetobacter baumannii.. Critical care medicine. 45:e633-e639. 2017
23. Transmission of methicillin-resistant Staphylococcus aureus to health care worker gowns and gloves during care of residents in Veterans Affairs nursing homes.. American journal of infection control. 45:947-953. 2017
24. Infrequent Use of Isolation Precautions in Nursing Homes: Implications for an Evolving Population.. Journal of the American Geriatrics Society. 65:472-473. 2017
25. Microbiological effect of mupirocin and chlorhexidine for Staphylococcus aureus decolonization in community and nursing home based adults.. Diagnostic microbiology and infectious disease. 88:53-57. 2017
26. Perceptions of Gown and Glove Use to Prevent Methicillin-resistant Staphylococcus aureus Transmission in Nursing Homes.. Journal of the American Medical Directors Association. 18:158-161. 2016
27. Healthcare-associated infections in the elderly: what's new.. Current opinion in infectious diseases. 29:388-93. 2016
28. Strategies to Prevent MRSA Transmission in Community-Based Nursing Homes: A Cost Analysis.. Infection control and hospital epidemiology. 37:962-966. 2016
29. Transmission Clusters of Methicillin-Resistant Staphylococcus Aureus in Long-Term Care Facilities Based on Whole-Genome Sequencing.. Infection control and hospital epidemiology. 37:685-91. 2016
30. Correction: Antibodies to S. aureus LukS-PV Attenuated Subunit Vaccine Neutralize a Broad Spectrum of Canonical and Non-Canonical Bicomponent Leukotoxin Pairs.. PloS one. 10:-. 2015
31. Antibodies to S. aureus LukS-PV Attenuated Subunit Vaccine Neutralize a Broad Spectrum of Canonical and Non-Canonical Bicomponent Leukotoxin Pairs.. PloS one. 10:-. 2015
32. Specific serum IgG at diagnosis of Staphylococcus aureus bloodstream invasion is correlated with disease progression.. Journal of proteomics. 1-7. 2015
33. Transmission of Methicillin-Resistant Staphylococcus aureus (MRSA) to Healthcare Worker Gowns and Gloves During Care of Nursing Home Residents.. Infection control and hospital epidemiology. 36:1050-7. 2015
34. Prior colonization is associated with increased risk of antibiotic-resistant Gram-negative bacteremia in cancer patients.. Diagnostic microbiology and infectious disease. 79:73-6. 2014
35. Infection prevention in the cancer center.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 57:579-85. 2013
36. A randomized controlled trial of enhanced cleaning to reduce contamination of healthcare worker gowns and gloves with multidrug-resistant bacteria.. Infection control and hospital epidemiology. 34:487-93. 2013
37. Association between methicillin-resistant Staphylococcus aureus colonization and infection may not differ by age group.. Infection control and hospital epidemiology. 34:93-5. 2012
38. Surveillance definitions of infections in long-term care facilities: revisiting the McGeer criteria.. Infection control and hospital epidemiology. 33:965-77. 2012
39. Lower antibody levels to Staphylococcus aureus exotoxins are associated with sepsis in hospitalized adults with invasive S. aureus infections.. The Journal of infectious diseases. 206:915-23. 2012
40. USA300 methicillin-resistant Staphylococcus aureus bacteremia and the risk of severe sepsis: is USA300 methicillin-resistant Staphylococcus aureus associated with more severe infections?. Diagnostic microbiology and infectious disease. 70:285-90. 2011
41. Systematic review of measurement and adjustment for colonization pressure in studies of methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, and clostridium difficile acquisition.. Infection control and hospital epidemiology. 32:481-9. 2011
42. Comparison of the methicillin-resistant Staphylococcus aureus acquisition among rehabilitation and nursing home residents.. Infection control and hospital epidemiology. 32:244-9. 2011
43. Staphylococcus aureus infections in US veterans, Maryland, USA, 1999-2008.. Emerging infectious diseases. 17:441-8. 2011
44. Persistent Staphylococcus aureus colonization is not a strongly heritable trait in Amish families.. PloS one. 6:-. 2011
45. Illicit drug use and risk for USA300 methicillin-resistant Staphylococcus aureus infections with bacteremia.. Emerging infectious diseases. 16:1419-27. 2010
46. Characteristics of healthcare-associated infections contributing to unexpected in-hospital deaths.. Infection control and hospital epidemiology. 31:864-6. 2010
47. Prolonged colonization with the methicillin-resistant Staphylococcus aureus strain USA300 among residents of extended care facilities.. Infection control and hospital epidemiology. 31:838-41. 2010
48. Predictive ability of positive clinical culture results and International Classification of Diseases, Ninth Revision, to identify and classify noninvasive Staphylococcus aureus infections: a validation study.. Infection control and hospital epidemiology. 31:694-700. 2010
49. Assessment of the 48-hour rule for identifying community-associated methicillin-resistant Staphylococcus aureus infection complicated by bacteremia.. Infection control and hospital epidemiology. 31:657-9. 2010
50. Targeted surveillance of methicillin-resistant Staphylococcus aureus and its potential use to guide empiric antibiotic therapy.. Antimicrobial agents and chemotherapy. 54:3143-8. 2010
51. Translation of clinical research into practice: defining the clinician scientist.. Family medicine. 41:440-3. 2009
52. Colonization sites of USA300 methicillin-resistant Staphylococcus aureus in residents of extended care facilities.. Infection control and hospital epidemiology. 30:313-8. 2009
53. Peptide nucleic acid fluorescent in situ hybridization for hospital-acquired enterococcal bacteremia: delivering earlier effective antimicrobial therapy.. Antimicrobial agents and chemotherapy. 52:3558-63. 2008
54. Detection of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci on the gowns and gloves of healthcare workers.. Infection control and hospital epidemiology. 29:583-9. 2008
55. Disparities in the use of immunomodulators and biologics for the treatment of inflammatory bowel disease: a retrospective cohort study.. Inflammatory bowel diseases. 14:13-9. 2008
56. Skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus USA300 clone.. Emerging infectious diseases. 13:1195-200. 2007
57. Staphylococcus aureus colonization in community-dwelling people with spinal cord dysfunction.. Archives of physical medicine and rehabilitation. 88:979-83. 2007
58. Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: Position statement from the Joint SHEA and APIC Task Force.. American journal of infection control. 35:73-85. 2007
59. Comparison of mortality risk associated with bacteremia due to methicillin-resistant and methicillin-susceptible Staphylococcus aureus.. Infection control and hospital epidemiology. 28:273-9. 2007
60. Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: position statement from the Joint SHEA and APIC Task Force.. Infection control and hospital epidemiology. 28:249-60. 2007
61. Novel ways of preventing antibiotic-resistant infections: what might the future hold?. American journal of infection control. 34:469-75. 2006
62. Prevalence and natural history of colonization with fluoroquinolone-resistant gram-negative bacilli in community-dwelling people with spinal cord dysfunction.. Archives of physical medicine and rehabilitation. 87:1305-9. 2006
63. Risk factors for recurrence in patients with Staphylococcus aureus infections complicated by bacteremia.. Diagnostic microbiology and infectious disease. 55:179-84. 2006
64. Racial differences in disease phenotypes in patients with Crohn's disease.. Inflammatory bowel diseases. 12:192-8. 2006
65. Impact of admission hyperglycemia on hospital mortality in various intensive care unit populations.. Critical care medicine. 33:2772-7. 2005
66. Utility of the Chronic Disease Score and Charlson Comorbidity Index as comorbidity measures for use in epidemiologic studies of antibiotic-resistant organisms.. American journal of epidemiology. 161:483-93. 2005
67. Risk of mortality with a bloodstream infection is higher in the less severely ill at admission.. American journal of respiratory and critical care medicine. 171:616-20. 2004
68. Epidemiological risk factors for isolation of ceftriaxone-resistant versus -susceptible citrobacter freundii in hospitalized patients.. Antimicrobial agents and chemotherapy. 47:2882-7. 2003
69. Fluoroquinolone use and Clostridium difficile-associated diarrhea.. Emerging infectious diseases. 9:730-3. 2003
70. Rates of hand disinfection associated with glove use, patient isolation, and changes between exposure to various body sites.. American journal of infection control. 31:97-103. 2003
71. Severity-of-illness markers as predictors of nosocomial infection in adult intensive care unit patients.. American journal of infection control. 30:139-44. 2002
72. Preventing nosocomial transmission of pulmonary tuberculosis: when may isolation be discontinued for patients with suspected tuberculosis?. Infection control and hospital epidemiology. 23:141-4. 2002
73. Risk factors for piperacillin-tazobactam-resistant Pseudomonas aeruginosa among hospitalized patients.. Antimicrobial agents and chemotherapy. 46:854-8. 2002
74. The effect of active surveillance for vancomycin-resistant enterococci in high-risk units on vancomycin-resistant enterococci incidence hospital-wide.. American journal of infection control. 30:40-3. 2002
75. Overuse of transthoracic echocardiography in the diagnosis of native valve endocarditis.. Archives of internal medicine. 162:1715-20. 2002
76. Risk factors for imipenem-resistant Pseudomonas aeruginosa among hospitalized patients.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 34:340-5. 2001
77. The relationship between age and fever magnitude.. The American journal of the medical sciences. 322:68-70. 2001
78. MRSA colonization and the risk of MRSA bacteraemia in hospitalized patients with chronic ulcers.. The Journal of hospital infection. 47:98-103. 2001
79. A survey on handwashing practices and opinions of healthcare workers.. The Journal of hospital infection. 45:318-21. 2000
80. Predicting methicillin resistance and the effect of inadequate empiric therapy on survival in patients with Staphylococcus aureus bacteremia.. Archives of internal medicine. 160:1001-4. 2000
81. Improved tuberculosis infection control practices in Maryland acute care hospitals.. American journal of infection control. 28:133-7. 2000
82. A randomized trial of surgical antimicrobial prophylaxis with and without vancomycin in organ transplant patients.. Clinical transplantation. 13:245-52. 1999
83. Adherence to asthma guidelines in general practices.. The Journal of asthma : official journal of the Association for the Care of Asthma. 36:381-7. 1999
84. Decreased seroprevalence for Toxoplasma gondii in Seventh Day Adventists in Maryland.. The American journal of tropical medicine and hygiene. 60:790-2. 1999
85. Vancomycin use in a hospital with vancomycin restriction.. Infection control and hospital epidemiology. 20:60-3. 1999
86. Photo quiz. Pulmonary tuberculosis.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 27:1137, 1318-9. 1998
87. Colonization with vancomycin-resistant enterococci in chronic hemodialysis patients.. American journal of kidney diseases : the official journal of the National Kidney Foundation. 32:254-7. 1998
88. Clostridium difficile infection is a risk factor for bacteremia due to vancomycin-resistant enterococci (VRE) in VRE-colonized patients with acute leukemia.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 25:1056-9. 1997
89. Natural history of colonization with vancomycin-resistant Enterococcus faecium.. Infection control and hospital epidemiology. 18:679-80. 1997
90. Recurrent vancomycin-resistant Enterococcus faecium bacteremia in a leukemia patient who was persistently colonized with vancomycin-resistant enterococci for two years.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 24:514-5. 1997
91. Ty1 transposition in Saccharomyces cerevisiae is nonrandom.. Genetics. 123:269-79. 1989
92. Effects of estradiol and tamoxifen on creatine kinase in rodent mammary carcinomas.. Cancer research. 47:1348-53. 1987
93. Comparison of latex agglutination and counterimmunoelectrophoresis for the detection of pneumococcal antigen in elderly pneumonia patients.. Journal of clinical microbiology. 22:553-7. 1985